People news from 11/18/05 News Brief

Share this article:


Johnson and Johnson executive Christine Poon received the American Geriatrics Society's Foundation for Health in Aging Discovery Award, in recognition of her philanthropic and business leadership and J&J's commitment to the well-being of older adults. The
Discovery Award recognizes trailblazers committed to translating research into improvements in the lives of older people. Poon is worldwide chairman of medicine & nutritionals and vice chairman of J&J.

Pozen, a pharmaceutical company focused primarily on products for the treatment of acute and chronic pain, migraine and other pain-related conditions, announced the appointment of Everardus Orlemans as VP, clinical research. Orlemans will be responsible for all the company's efforts in the conduct of clinical trials to support New Drug Application (NDA) submissions to the FDA and other worldwide regulatory bodies.

Abelson-Taylor has hired four new clinical research associates. Jonathan Davila was previously a consultant-manufacturing engineer at Nanosphere, a biopharmaceutical company specializing in DNA diagnostics. Prior to joining Abelson- Taylor, Rose Marie Cassey served as a department supervisor at Mc-Master-Carr, an industrial supply distribution company in Dayton, N.J.
Born in Romania, Radu Postelnicu has an international background and experience in healthcare. He will be working on some of the agency's oncology accounts. Lucy Chung comes to Abelson-Taylor after graduating from Northwestern University with a B.S. in biomedical engineering. She will work on insomnia and oncology products. 

The Hal Lewis Group, an independent firm specializing in pharmaceutical and healthcare branding and marketing services, has announced the following new hires: Matt Altier
as senior account executive, and Heather Derenthal as account executive. Altier was previously an account executive at Euro RSCG Life MetaMax, while Derenthal comes to the company from Palio Communications, where she was an account executive.

Chamberlain Communications Group, an independent healthcare public relations agency, has recruited Mel Granick as SVP, media services; Nancie Steinberg as VP, media services; and Michelle Strier as VP to lead the agency's global and U.S. teams for Pfizer's Zithromax antibiotic.
In addition, Lisa Draho has been elevated to VP leading the firm's team for Novartis' Lotrel antihypertensive.


PDI, a sales and marketing services provider to the biopharmaceutical and medical devices and diagnostics industries, has hired Michael Cotton as executive director of business development, a newly created position within the performance sales teams business unit. Cotton will be responsible for identifying and cultivating prospective client relationships, and overseeing the process used by PDI in business development. Cotton brings to the job more than 18 years of experience in operations and new business development within the pharmaceutical, dental and chemical industries.

Patient Marketing Group has hired Tim Loretangeli as VP, creative services. Most recently, Tim was SVP/creative director with Dudnyk Advertising in Horsham, Pa. Laurie Bartolomeo has also joined the Patient Marketing Group as a senior copywriter. Prior to PMG, Laurie worked as a copy supervisor at Dudnyk Healthcare Group and as a senior copywriter at Adient.


Communications Media Inc. has announced the recent addition of Robert Girondi as EVP, media research and development. Girondi joins CMI with an extensive applications- based marketing background that includes the manufacturer, agency and supplier sides of the pharmaceutical industry. He recently retired from AstraZeneca and its legacy companies, where he served most recently as senior director of agency network relations and media planning.

Gene Snyder, former director and team leader, publishing, for Pfizer, joins clinical outreach provid

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...